Compounds > n(6)-carboxymethyllysine
Page last updated: 2024-09-03

n(6)-carboxymethyllysine and Pregnancy in Diabetes

n(6)-carboxymethyllysine has been researched along with Pregnancy in Diabetes in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brings, S; Ejdesjö, A; Eriksson, UJ; Fleming, T; Fred, RG; Nawroth, PP1
Braekke, K; Hanssen, K; Harsem, NK; Staff, AC; Torjussen, T1
Eriksson, UJ; Gittenberger-de Groot, AC; Molin, DG; Roest, PA; Schalkwijk, CG; van Iperen, L; Wentzel, P1
Aston, CE; Basu, A; Chirindel, A; Garg, SK; Hammad, SM; Hanssen, KF; Henriksen, T; Jenkins, AJ; Kalyanaraman, V; Lorentzen, B; Lyons, TJ; Menard, MK; Nankervis, AJ; Scardo, JA; Scholz, H; Stanley, JR; Torjesen, PA; Wu, M; Yu, Y1

Other Studies

4 other study(ies) available for n(6)-carboxymethyllysine and Pregnancy in Diabetes

ArticleYear
Receptor for advanced glycation end products (RAGE) knockout reduces fetal dysmorphogenesis in murine diabetic pregnancy.
    Reproductive toxicology (Elmsford, N.Y.), 2016, Volume: 62

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dinoprost; Embryo, Mammalian; Embryonic Development; Female; Fetal Development; Fetal Resorption; Gene Expression; Liver; Lysine; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Pregnancy; Pregnancy in Diabetics; Pyruvaldehyde; Receptor for Advanced Glycation End Products

2016
Advanced glycation end products in pregnancies complicated with diabetes mellitus or preeclampsia.
    Hypertension in pregnancy, 2008, Volume: 27, Issue:4

    Topics: Adult; Biomarkers; Case-Control Studies; Diabetes, Gestational; Dinoprost; Female; Ferric Compounds; Glycation End Products, Advanced; Humans; Lysine; Oxidative Stress; Pre-Eclampsia; Pregnancy; Pregnancy in Diabetics; Vitamin E; Young Adult

2008
Specific local cardiovascular changes of Nepsilon-(carboxymethyl)lysine, vascular endothelial growth factor, and Smad2 in the developing embryos coincide with maternal diabetes-induced congenital heart defects.
    Diabetes, 2009, Volume: 58, Issue:5

    Topics: Animals; Congenital Abnormalities; Disease Models, Animal; Embryo, Mammalian; Female; Glycation End Products, Advanced; Heart Defects, Congenital; Humans; Infant, Newborn; Lysine; Pregnancy; Pregnancy in Diabetics; Rats; Rats, Sprague-Dawley; Risk Factors; Smad2 Protein; Vascular Endothelial Growth Factor A; Wound Healing

2009
Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes.
    BJOG : an international journal of obstetrics and gynaecology, 2012, Volume: 119, Issue:12

    Topics: Adult; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 1; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique; Glycation End Products, Advanced; Humans; Imidazoles; Linear Models; Lysine; Pre-Eclampsia; Pregnancy; Pregnancy in Diabetics; Prospective Studies; Receptor for Advanced Glycation End Products; Receptors, Immunologic

2012